Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tedizolid Suppressive Antimicrobial Therapy

NCT04662736 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04662736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tedizolid Suppressive Antimicrobial Therapy
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
April 1, 2021
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone and joint infection